EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges

Chiara Ragusa iD, Valentina Oliveri iD

The Chemical Record · 2026-07 · 26 (7)

DOI: 10.1002/tcr.70179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Chemical Record, online erschienen am 22.06.2026. Verfasst von Chiara Ragusa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, Italy. Hauptthemen laut MEDLINE: Cuproptosis, Neoplasms, Copper, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERMES, Università di Catania, University of Catania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer continues to be the primary cause of death despite significant progress in medicine, and finding effective therapies remains a challenge. New treatments are needed to minimize the harmful effects on the body and increase the selectivity of drugs. These therapies must also overcome cancer cell resistance and prevent metastasis. Metal‐based drugs are becoming increasingly crucial for treating tumors, and copper ion‐based systems and nanoparticles have been identified as having unique properties and anticancer potential. Given the key role exerted by Cu in the etiology, severity, and progression of cancer diseases, it could be a vulnerable point to target for hindering cancer development. After thoroughly analyzing what is known about the mechanism of cancer cell death through a Cu‐dependent mechanism, known as cuproptosis, and its potential links with ferroptosis, we report some systems that, when coadministered with copper ions, can trigger this type of cell death. This study investigates the effectiveness of cuproptosis inducers against various types of cancers. Are these cuproptosis inducers effective in combating cancer? What limitations or disadvantages might be associated with their use? This article aims to answer these questions based on the current knowledge in this evolving area of cancer research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuproptosisNeoplasmsCopperAntineoplastic AgentsHumansAnimalsFerroptosis

Stichwörter der Autor:innen

cancercancer resistancecancer therapycause of deathcopper ionophorescopper‐based nanomaterialscuproptosisprogrammed cell death

Substanzen

CopperAntineoplastic Agents

Autor:innen und Institutionen

  • Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, Italy.

ORCID-Profile: Chiara Ragusa, Valentina Oliveri

Förderung

  • ERMES
  • Università di Catania
  • University of Catania

Zitieren

APA

Ragusa, C., & Oliveri, V. (2026). Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges. The Chemical Record, 26(7). https://doi.org/10.1002/tcr.70179

Vancouver

Ragusa C, Oliveri V. Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges. The Chemical Record. 2026;26(7). doi:10.1002/tcr.70179

BibTeX
@article{Ragusa2026,
  author = {Ragusa, Chiara and Oliveri, Valentina},
  title = {Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges},
  journal = {The Chemical Record},
  year = {2026},
  volume = {26},
  number = {7},
  doi = {10.1002/tcr.70179}
}
Kostenlos starten →